Results 161 to 170 of about 91,813 (297)
FDA's 2025 removal of black box warnings on menopausal hormone therapy. [PDF]
Zeeshan F, Saqlain A.
europepmc +1 more source
Polymerized Pro‐Estrogen Microneedles via Two Photon Polymerization
Acrylic pro‐drugs of 17β‐estradiol were subjected to spatially controlled two‐photon polymerization to create bespoke microneedle geometries with potential biomedical applications for long‐term transdermal hormone delivery. ABSTRACT Two‐photon polymerization (TPP) is a powerful technique to create microscale structures with high precision, offering ...
Yang Lou +6 more
wiley +1 more source
Menopausal hormone therapy for breast cancer patients: what is the current evidence? [PDF]
Glynne S +10 more
europepmc +1 more source
Antithrombin: Deficiency, Diversity, and the Future of Diagnostics
ABSTRACT Our healthcare system provides reactive sick‐care, treating patients after symptoms have appeared by prescription of generic and often suboptimal therapy. This strategy brings along high costs and high pressure which is not sustainable.
Mirjam Kruijt +2 more
wiley +1 more source
Long-term amyloid PET and MRI outcomes in a menopausal hormone therapy trial. [PDF]
Kantarci K +27 more
europepmc +1 more source
Abstract Aim Aromatase is the key enzyme in the biosynthesis of 17β‐estradiol, the most potent estrogen, which has pleiotropic neuroprotective properties. Aromatase levels increase in the brain after stroke, and its gene variants increase susceptibility to stroke. This study aims to determine whether aromatase overexpression improves stroke outcome and
Lindsay Gallagher +8 more
wiley +1 more source
Abstract Background Altered interoception, the sense of signals from inside the body, is linked to chronic pain. No studies to date have examined whether interoceptive sensibility, one's self‐reported beliefs about the body and tendencies to be internally focused, changes following participation in an interdisciplinary pain management program (IPMP ...
Stephanie Voss +4 more
wiley +1 more source
Menopausal Hormone Therapy-Risks, Benefits and Emerging Options: A Narrative Review. [PDF]
Arnautu AM +4 more
europepmc +1 more source
Female hormonal exposures and neuromyelitis optica symptom onset in a multicenter study [PDF]
Alvarez, Enrique, Cross, Anne H, et al,
core +2 more sources
Uric Acid in Metabolic Dysfunction‐Associated Steatotic Liver Disease
MASLD is the most prevalent chronic liver disease worldwide, yet effective pharmacological treatments remain limited. Hyperuricemia is now recognized as a key driver of hepatic steatosis, inflammation, and fibrosis, with elevated serum uric acid levels independently predicting hepatocellular carcinoma and liver‐related mortality.
Rong Wang +5 more
wiley +1 more source

